UK's NICE Backs Funding For Olympus Plasma System For BPH
Executive Summary
The bipolar electrosurgery Plasma system reduces the risks associated with conventual monopolar transurethral resection of the prostate and works out cheaper, according to health technology assessment body NICE.
You may also be interested in...
UK's NICE Recommends Boston Scientific’s Rezum Steam Treatment For BPH
The UK’s NICE has recommended the use of Boston Scientific’s Rezum system for treatment of enlarged prostate. The minimally invasive procedure involves injecting steam to destroy excess prostate tissue.
EMA Probe Finds No Link Between GLP-1s And Suicidal Thoughts & Actions
After reviewing the evidence from non-clinical studies, clinical trials, post-marketing surveillance data and other studies, the European Medicines Agency said there was no need to update the product information for 11 diabetes and weight management drugs.
English Funding For Aquipta Targets AbbVie’s Migraine Drug To 170,000 People
Aquipta is the first oral treatment that NICE has recommended for preventing chronic migraines in the fourth-line setting, and the second oral treatment for episodic migraines in the same setting. The drug has already secured reimbursement in Scotland, Sweden and Israel.